510(k) K202150
K202150 is an FDA 510(k) premarket notification submitted by C.R. Bard, Inc. for the device "GlidePath 7.5F Long-Term Dialysis Catheter". The FDA issued a decision of Substantially Equivalent (kit) on November 18, 2020. The device falls under product code MSD (Catheter, Hemodialysis, Implanted), a Class II device regulated under 21 CFR 876.5540. C.R. Bard, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESK (Substantially Equivalent (kit))
- Decision Date
- November 18, 2020
- Date Received
- August 3, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Catheter, Hemodialysis, Implanted
- Device Class
- Class II
- Regulation Number
- 876.5540
- Review Panel
- GU
- Submission Type